Biotechnology argenx Receives Positive CHMP Opinion for Efgartigimod for the Treatment of Adult Patients with Generalized Myasthenia Gravis in Europe June 24, 2022
Biotechnology CLASS ACTION UPDATE for RSKD, AXSM and SPRO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders June 23, 2022
Biotechnology AXSM LOSS ALERT: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AXSM June 23, 2022
Biotechnology Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of ACADIA Pharmaceuticals, Inc. (ACAD) Investigation June 23, 2022
Biotechnology BioNTech Receives Priority Medicines (PRIME) Designation from EMA for Enhanced Regulatory Support of CAR-T Candidate BNT211 in Testicular Cancer June 23, 2022
Search
Search
